Peripheral benzodiazepine receptors in platelets of epileptic patients.

British Journal of Clinical Pharmacology

Volumn 36, Issue 1, 1993, Pages 71-74

  Larkin, JG ^a   McKee, PJ ^a   Thompson, GG ^a   Brodie, MJ ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE; BENZODIAZEPINE RECEPTOR; CARBAMAZEPINE; CLOBAZAM; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; PHENYTOIN; VALPROIC ACID;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG RECEPTOR BINDING; DRUG TOLERANCE; EPILEPSY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RECEPTOR DENSITY; THROMBOCYTE;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; BENZODIAZEPINONES; BLOOD PLATELETS; COMPARATIVE STUDY; EPILEPSY; FEMALE; HUMAN; ISOQUINOLINES; MALE; MIDDLE AGE; RECEPTORS, GABA-A; SEX CHARACTERISTICS;

EID: 0027279537     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.1993.tb05895.x     Document Type: Article

References (26)

1. Current status of the 1,4‐ and 1,5‐benzodiazepines in the treatment of epilepsy: the place of clobazam
2. Tolerance to the anticonvulsant effect of benzodiazepines
3. Benzodiazepine receptors and their relationship to the treatment of epilepsy
4. Relationships between CSF drug concentrations, receptor binding characteristics and pharmacokinetic and pharmacokinetic properties of selected 1,4‐substituted benzodiazepines
5. Molecular determinants of benzodiazepine receptor affinities and anticonvulsant activities
6. Peripheral benzodiazepine binding sites
7. Peripheral type benzodiazepine receptors
8. Relationship of agonist efficacy to changes in GABA sensitivity and anticonvulsant tolerance following chronic benzodiazepine ligand exposure
9. The benzodiazepines: anxiolytic and withdrawal effects
10. Differential mediation of the anticonvulsant effects of carbamazepine and diazepam
11. Contingent tolerance to carbamazepine: a peripheral‐type benzodiazepine mechanism
12. Central and peripheral benzodiazepine receptors in rat brain and platelets: effects of treatment with diazepam and clobazam
13. Peripheral benzodiazepine binding sites on platelet membranes are increased during diazepam treatment of anxious patients
14. 3H]PK1195 to platelets of epileptic patients
15. Antiepileptic drug monitoring at the epilepsy clinic: a prospective evaluation
16. Decreased peripheral benzodiazepine sites in platelets of neuroleptic‐treated schizophrenics
17. A simplification of the protein assay method of Lowry et al which is more generally applicable
18. PK11195 antagonism of pyrethroid‐induced proconvulsant activity
19. Pro‐ and anticonvulsant properties of PK11195, a ligand for benzodiazepine binding sites: development of tolerance
20. The peripheral benzodiazepine receptor ligang Ro5–4864 induces supraspinal convulsions in rabbits. Reversal by the central benzodiazepine antagonist Ro 15–1788
21. The involvement of ‘peripheral’ benzodiazepine receptor type (omega 3) in the tolerance to the electroencephalographic effects of benzodiazepines in rats: comparison of diazepam and clonazepam
22. Tolerance to the anti‐pentylenetetrazol effects of diazepam in the mouse
23. N‐Desemethylclobazam: a possible alternative to clobazam in the treatment of epilepsy?
24. Differences between the tolerance characteritics of two anticonvulsant benzodiazepines
25. Rapid induction of lorazepam dependence and reversal with flumazenil
26. Feasability of reversing benzodiazepine tolerance with flumazenil